Does the dangerous new Middle East coronavirus have an African origin? | Cities might not be as prepared as they think for bioterrorism | Researchers identify vulnerabilities of the deadly Ebola virus | Prep for the inevitable: how do we tackle resistant malaria? | Scientists willing to take a risk are setting up individual research in rented lab space | Monoclonal antibody effective against norovirus (ASM) | H7N9 study in human tissues adds to pandemic concerns | Russia threatens Georgian trade over U.S. biolab | Pentagon equips Kenya, Uganda against WMD threats | WHO travel advice for pilgrimages given MERS coronavirus | Luminex Corporation celebrates shipping of 10,000th instrument | Study shows how MERS and SARS are alike, differ | Mobile and novel chemical warfare agent neutralization | Homeland Security’s future home: A former mental hospital

See what we’re reading this week at Global Biodefense on topics like origins of the MERS coronavirus, Russian opposition to US biolab in Georgia, H7N9 findings and more…

Does the dangerous new Middle East coronavirus have an African origin? (Univ of Bonn)

Cities might not be as prepared as they think for bioterrorism (Defense One)

Researchers identify vulnerabilities of the deadly Ebola virus (Mount Sinai Hospital)

Prep for the inevitable: how do we tackle resistant malaria? (The Guardian)

Scientists willing to take a risk are setting up individual research in rented labs (Nature)

Monoclonal antibody effective against norovirus (ASM) .pdf

H7N9 study in human tissues adds to pandemic concerns (CIDRAP)

Russia threatens Georgian trade over U.S. biolab (NTI GSN)

Pentagon equips Kenya, Uganda against WMD threats (NTI GSN)

WHO travel advice for pilgrimages given MERS coronavirus (WHO)

Luminex Corporation celebrates shipping of 10,000th instrument (BioNewsTX)

Study shows how MERS and SARS are alike, differ (CIDRAP)